C

Clinical Endpoints | Scottsdale, AZ

Research site
(Unclaimed)
Location
9977 North 95th Street, Suite 101, Scottsdale, Arizona, United States of America
Site insights

Top conditions

Alzheimer Disease (4 trials)

Migraine Disorders (1 trial)

Top treatments

CY6463
BOTOX
ACU193
Simufilam
NE3107

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

2 of 5
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
Simufilam 50 mg or 100 mg for Mild-to-Moderate Alzheimer's Disease (REFOCUS-ALZ)

A 76-week safety and efficacy study of simufilam (PTI-125) given twice daily to participants with mild-to-moderate Alzheimer's disease (AD) for 76 we...

Active, not recruiting
Alzheimer Disease
Drug: Placebo
Drug: Simufilam

Migraine is a neurological disease characterized by moderate or severe headache, associated with nausea, vomiting, and/or sensitivity to light and so...

Active, not recruiting
Episodic Migraine
Drug: BOTOX
Drug: Placebo

Trial sponsors

AbbVie logo

AbbVie (1 trial)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems